FDA Drug recall D-0120-2020
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's…
- FDA Drug
- Class III
- terminated
- Published 2019-10-02
On 2019-10-02 the FDA classified a Class III recall of minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's… by Epi Health, citing failed Dissolution Specifications:.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0120-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-08-26 |
| Published | 2019-10-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Epi Health |
| Distribution | n/a |
Product
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
Reason
Failed Dissolution Specifications:
Identifiers
| code_info | Lot# T900093, Exp 11/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0120-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.